TY  - JOUR

T1  - Evaluating the risk of gene therapy

JO  - The Lancet Oncology

UR  - https://doi.org/10.1016/s1470-2045(03)01047-7

PY  - 2003/04/01

AU  - Wilkinson E

ED  - 

DO  - DOI: 10.1016/s1470-2045(03)01047-7

PB  - Elsevier BV

VL  - 4

IS  - 4

SP  - 196

EP  - 196

Y2  - 2025/11/30

ER  -